Combined inhibition of apoptosis and complement improves neural graft survival of embryonic rat and porcine mesencephalon in the rat brain - PubMed (original) (raw)
. 2002 Oct;177(2):376-84.
doi: 10.1006/exnr.2002.8007.
Affiliations
- PMID: 12429184
- DOI: 10.1006/exnr.2002.8007
Combined inhibition of apoptosis and complement improves neural graft survival of embryonic rat and porcine mesencephalon in the rat brain
F Cicchetti et al. Exp Neurol. 2002 Oct.
Abstract
To define potential mechanisms of cell death during neural cell transplantation, we investigated the role of intracellular caspase activation in combination with the activation of serum complement. We demonstrated that ventral mesencephalic (VM) cells are susceptible to complement-mediated cell lysis that can be blocked with an anti-C5 complement inhibitor (18A10). We also determined that incubating freshly isolated allogenic VM cells with the caspase inhibitor 1-3-Boc-aspartyl(Ome)-fluoromethyl ketone (BAF), followed by immediate striatal implantation, led to a 2.5-fold increase in tyrosine hydroxylase (TH) cell survival 12 weeks postimplantation (P < 0.05). In contrast, overnight incubation with BAF followed by striatal implantation led to a 2-fold reduction in TH cell survival at 12 weeks (P < 0.05). Using the optimal BAF treatment and complement inhibition, we tested the hypothesis that these treatments would lead to increased cell survival in both allogeneic and xenogeneic transplantation models. We transplanted cell suspensions of (a) rat E14 VM or VM treated with (b) BAF alone, (c) anti-C5, or (d) a combination of BAF and anti-C5. There was a significant increase in the relative number of TH-positive cells in the BAF/anti-C5 group versus control at 12 weeks posttransplantation. Similar results were achieved in a pig to rat xenotransplant paradigm. A neuronal xenograft marker (70-kDa neurofilament) also demonstrated relative increases in graft volume in the BAF/anti-C5 treatment group. These studies indicate that more than one mechanism can mediate cell death during neural cell transplantation and that a combined treatment using caspase and complement inhibition can significantly improve cell survival.
Similar articles
- Fetal porcine ventral mesencephalon graft. Determination of the optimal gestational age for implantation in parkinsonian patients.
HogenEsch RI, Koopmans J, Copray JC, van Roon WM, Kema I, Molenaar G, Go KG, Staal MJ. HogenEsch RI, et al. Exp Brain Res. 2000 Jun;132(3):345-50. doi: 10.1007/s002210000346. Exp Brain Res. 2000. PMID: 10883382 - Microcarrier enhanced survival of human and rat fetal ventral mesencephalon cells implanted in the rat striatum.
Saporta S, Borlongan C, Moore J, Mejia-Millan E, Jones SL, Bonness P, Randall TS, Allen RC, Freeman TB, Sanberg PR. Saporta S, et al. Cell Transplant. 1997 Nov-Dec;6(6):579-84. doi: 10.1177/096368979700600608. Cell Transplant. 1997. PMID: 9440867 - Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
Hurelbrink CB, Armstrong RJ, Luheshi LM, Dunnett SB, Rosser AE, Barker RA. Hurelbrink CB, et al. Exp Neurol. 2001 Sep;171(1):46-58. doi: 10.1006/exnr.2001.7749. Exp Neurol. 2001. PMID: 11520120 - Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient.
Karlsson J, Petersén A, Gidö G, Wieloch T, Brundin P. Karlsson J, et al. Cell Transplant. 2005;14(5):301-9. doi: 10.3727/000000005783983089. Cell Transplant. 2005. PMID: 16052911
Cited by
- Strategies for promoting anti-seizure effects of hippocampal fetal cells grafted into the hippocampus of rats exhibiting chronic temporal lobe epilepsy.
Rao MS, Hattiangady B, Rai KS, Shetty AK. Rao MS, et al. Neurobiol Dis. 2007 Aug;27(2):117-32. doi: 10.1016/j.nbd.2007.03.016. Epub 2007 May 23. Neurobiol Dis. 2007. PMID: 17618126 Free PMC article. - Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy.
Hattiangady B, Rao MS, Shetty AK. Hattiangady B, et al. Exp Neurol. 2008 Aug;212(2):468-81. doi: 10.1016/j.expneurol.2008.04.040. Epub 2008 May 15. Exp Neurol. 2008. PMID: 18579133 Free PMC article. - Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease.
Sánchez-Pernaute R, Ferree A, Cooper O, Yu M, Brownell AL, Isacson O. Sánchez-Pernaute R, et al. J Neuroinflammation. 2004 May 17;1(1):6. doi: 10.1186/1742-2094-1-6. J Neuroinflammation. 2004. PMID: 15285796 Free PMC article. - Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease.
Hedlund E, Pruszak J, Lardaro T, Ludwig W, Viñuela A, Kim KS, Isacson O. Hedlund E, et al. Stem Cells. 2008 Jun;26(6):1526-36. doi: 10.1634/stemcells.2007-0996. Epub 2008 Apr 3. Stem Cells. 2008. PMID: 18388307 Free PMC article. - Systems approaches to preventing transplanted cell death in cardiac repair.
Robey TE, Saiget MK, Reinecke H, Murry CE. Robey TE, et al. J Mol Cell Cardiol. 2008 Oct;45(4):567-81. doi: 10.1016/j.yjmcc.2008.03.009. Epub 2008 Mar 19. J Mol Cell Cardiol. 2008. PMID: 18466917 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- R44 HD095784/HD/NICHD NIH HHS/United States
- P50 NS-39793-02/NS/NINDS NIH HHS/United States
- NS30064/NS/NINDS NIH HHS/United States
- P51RR00168-39/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous